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OBJECTIVE: Obesity results in insulin resistance. Bariatric surgery for obese individuals induces weight loss, improves insulin
sensitivity, and lowers insulin levels. We investigated the mechanisms of this improvement.
DESIGN: Insulin receptor (IR) content, IR signaling, and adiponectin levels were measured in nine morbidly obese subjects
before and after bariatric surgery.
SUBJECTS: Seven female and two male, average age 4472y, BMI 440 kg/m2 and/or at least 100 lbs over ideal body weight,
undergoing elective bariatric surgery.
MEASUREMENTS: Before surgery BMI, fasting plasma glucose, adiponectin, and insulin levels were measured. A fasting muscle
biopsy was obtained from the vastus lateralis for IR concentration and autophosphorylation activity measurements. These
procedures were repeated 1 y after surgery.
RESULTS: At 1 y after surgery, the subjects had lost an average of 48.375.6 kg (Po0.001), insulin sensitivity had significantly
increased as determined by the minimal model (SI 0.7270.18 vs 3.8671.43, Po0.05), and IR content had increased two-fold in
muscle (2.170.4 vs 4.370.7 ng/mg protein, Po0.01). The increase in IR content was related to fasting insulin levels. In the subjects
with the lowest IR function, there was also an increase in IR function. Plasma adiponectin increased by 40% following weight loss
(7.471.6 pre vs 10.371.3 mg/ml post, Po0.05). There was no significant change in muscle content of the IR inhibitor, PC-1.
CONCLUSION: Increased IR content, most likely regulated by insulin levels, may be one contributor to the increased insulin
sensitivity that occurs when morbidly obese patients undergo bariatric surgery.
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Introduction
Obesity is a major problem in the United States and other
developed countries. In addition to the many adverse effects
of being overweight, obesity is associated with hyperinsuli-
nemia, insulin resistance, and an increased risk for
type-II diabetes. Although this relationship has long been
recognized, the mechanism(s) whereby increased fat mass
negatively impacts insulin action in key insulin-sensitive
tissues, most notably skeletal muscle, remains unknown.
Cellular insulin signaling is initiated by binding of insulin
to the alpha subunits of the insulin receptor (IR). This
binding results in a conformational change in the beta
subunits of the IR, allowing ATP to bind with subsequent
autophosphorylation of multiple tyrosine residues.1–3 These
events in the IR are followed by tyrosine phosphorylation
and activation of downstream signaling molecules.4,5 In vitro
evidence from numerous studies in cultured cell systems6,7
indicate that hyperinsulinemia downregulates IR content. In
vivo, skeletal muscle from obese subjects demonstrates
impaired insulin action at the earliest steps of IR signaling.
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For instance, muscle biopsies from obese subjects have
reduced IR content and impaired insulin-induced activation
of IR autophosphorylation.8–10 We have demonstrated a
strong correlation between increasing levels of obesity,
hyperinsulinemia, and decreasing IR signaling capacity in
muscle from Pima Indians.11
Weight loss is known to improve insulin sensitivity in
obese subjects.12–14 In morbidly obese individuals who are
insulin resistant, the major weight loss induced by gastric
surgery (bariatric surgery) is associated with a marked
increase in insulin action in muscle.15,16 However, the effects
of this weight loss on IR signaling capacity in muscle have
not been studied. Since this surgical procedure is known to
lower the insulin levels, it is possible that upregulation of IR
content and/or function is a contributing mechanism
improving insulin action. In the present study, we examined
the changes in insulin levels, insulin sensitivity, and
muscle IR content and function, in morbidly obese subjects
before and after surgically induced weight loss. We also
measured the changes of circulating adiponectin, a hormone
produced by adipocytes that appears to increase insulin
sensitivity.17
Materials and methods
Subjects
Morbidly obese (BMI440 kg/m2 and/or at least 100 lbs over
ideal body weight) subjects (seven female and two male,
average age 4472y) were examined prior to and 1 y after
elective gastric surgery to induce weight loss at the Depart-
ment of Surgery, East Carolina University.18 Descriptive data
for the subjects are presented in Table 1. For seven patients,
the Roux-en-Y gastric bypass procedure was performed, and
the remaining two patients underwent banded gastro-
plasty.19 Previous characterization of morbidly obese subjects
undergoing gastric surgery demonstrated that, in the 12
months following surgery, body mass had stabilized and
remained significantly depressed, and insulin action drama-
tically improved.18 For data and sample collection prior to
surgery and at 12-month follow-up, subjects reported to the
laboratory at approximately 0800 h after a 12-h fast.
At 3 days prior to the study, subjects were instructed to
consume at least 250 g of carbohydrate per day. Body mass
and stature were measured and a fasting blood sample was
obtained for the measurement of plasma glucose, insulin,
and adiponectin levels. A muscle sample was obtained from
the vastus lateralis using the percutaneous needle biopsy
technique. All procedures were approved by the East
Carolina University Human Subjects Committee, and in-
formed consent was obtained before performing any experi-
mental procedures.
Insulin action
An insulin sensitivity (SI) was calculated on the basis of the
minimal model, as described by Finegood et al.20 SI is an
index of the ability of insulin to promote the disposal of
glucose during an in vitro glucose tolerance test (IVGTT). A
higher SI indicates an enhanced insulin sensitivity. Glucose
and insulin dosages were calculated on the basis of body
surface area, because of the high body mass of morbidly
obese subjects. Briefly, the IVGTT procedure consisted of
obtaining four baseline samples before the intravenous
injection of glucose (12 g/m2) at time zero and insulin
(1.5 U/m2) 20 min later. In all, 25 samples were obtained
between zero and 180 min and subsequently analyzed by
spectrophotometry for glucose (procedure HK 16-UV, Sigma,
St Louis, MO, USA) and by microparticle enzyme immu-
noassay for insulin (IMx, Abbott, Abbott Park, IL, USA). SI
was calculated with the minimal model of insulin action
(MINMOD, version 3.0).
Adiponectin
Plasma adiponectin levels were measured using a radio-
immunoassay for human adiponectin (Linco Research, St
Louis MO, USA). The assay utilizes 125I-labeled adiponectin
and an anti-adiponectin rabbit antiserum to determine
adiponectin concentrations by the double antibody/PEG
technique. Standards over the range of 1–200 ng/ml
were prepared using recombinant human adiponectin.
All plasma samples were diluted 1 : 200, yielding an effective
range of 0.2–40 mg/ml. The intra- and inter-assay coefficients
of variation at adiponectin concentrations in the range
of 3–15 mg/ml are 1.8–6.2 and 6.9–9.3%, respectively.
Plasma adiponectin levels measured in 40 paired samples
using this assay, and the enzyme-linked immunoabsorbent
assay (ELISA) developed by Arita and colleagues21
were similar (10.476.6 vs 10.175.5 mg/ml) and linearly
Table 1 Clinical characteristics of subjects before and after surgically induced weight loss
Variable Pre-Surgery Post-Surgery
Weight (kg) 137.476.2 (106.1–163.6) 89.174.1* (75.0–112.3)
BMI (kg/m2) 47.072.7 (36.0–56.5) 30.471.4* (25.1–37.6)
Fasting Insulin (mU/ml) 30.478.1 (5.0–68.8) 6.171.5w (2.5–15.1)
Fasting Glucose (mg/dl) 150727 (73–317) 7975w (55–92)
SI (min1(mU/ml)1) 0.7270.18 (0.18–1.39) 3.8671.43w (0.69–13.09)
Values are presented7the standard error with the range in parentheses. Pre-and post-surgery data are significantly different; *Po0.001, wPo0.05.
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related (r¼0.896, Po0.0001; RL Gingerich, unpublished
observation).
Preparation of muscle extracts
Soluble extracts were prepared from frozen muscle tissue to
measure the tissue content of IR, IR autophosphorylation
capacity, and PC-1 content. Approximately 50 mg of frozen
tissue was pulverized under liquid nitrogen. The resultant
powder was homogenized in 0.5 ml buffer (50 mM HEPES
HCl, 150 mM NaCl, 1 mM PMSF, 2mM leupeptin, and 2mM
pepstatin, pH 7.4) at 41C, using a polytron homogenizer
(Kinematica, Lucerne, Switzerland) for 10 s at a setting of 9.
Triton X-100 was added to a final concentration of 1%, and
the homogenates were solubilized for 60 min at 41C. The
solubilized homogenate was then centrifuged at 100 000 g for
60 min at 41C. The supernatants were collected and stored at
701C. Protein content of the muscle extracts was deter-
mined by the Bradford method.22
IR ELISA
IR content of muscle extracts was determined by specific
ELISA, as described previously.23 Briefly, microtiter 96-well
plates were coated with 2mg/ml of a monoclonal antibody to
the IR a-subunit (MA-20) for 18 h at 41C. After washing and
blocking the plate, solubilized cellular extract containing
10 mg protein of each sample was added to each well for
triplicate determination and allowed to bind overnight at
41C. Readout of bound IR was accomplished with the
sequential addition of biotinylated monoclonal anti-IR
antibody CT-1, peroxidase-conjugated streptavidin (Pierce,
Rockford, IL, USA), ELAST ELISA Amplification System (NEN
Research Products, Boston, MA, USA) for signal enhance-
ment, and TMB peroxidase substrate System (Kirkegaard &
Perry, Gaithersburg, MD, USA) for color development. The
absorption at 450 nm of each well was measured in a
microtiter plate reader (DuPont-NEN, Boston, MA, USA). IR
content for each sample was calculated as an average of
triplicate values.
IR autophosphorylation ELISA
The autophosphorylation capacity of muscle IR was deter-
mined in soluble extracts using an ELISA specific for IR
tyrosine phosphorylation, as described previously.11 In this
assay, solubilized cellular extract containing 10 pg IR was
added to each well of a 96-well microtiter plate coated with
2 mg/ml MA-20 and allowed to bind overnight. Immunocap-
tured IR was then incubated in 50 mM HEPES, 150 mM NaCl,
10 mM MgCl2, 2 mM MnCl2, 0.1% Triton X-100, 0.05% BSA,
10 mM ATP, pH 7.67100 nM insulin for 1 h at 221C. The
extent of tyrosine phosphorylation was then determined by
incubation with a biotinylated antiphosphotyrosine anti-
body (UBI, Lake Placid, NY, USA), followed by an identical
procedure for color development, as employed in the IR
content ELISA.
PC-1 content ELISA
Tissue content of membrane glycoprotein PC-1 was deter-
mined by specific ELISA, as described previously.23 The
protocol was similar to that described above for the IR ELISA
with the capture antibody to PC-1 provided by Dr I
Yamashina from Kyoto University, Kyoto, Japan. In addition,
2 mg muscle extract protein was added to each well, and the
standard curve is constructed by multiple dilutions of 0–
1.5 ng purified PC-1. The secondary antibody was a biotiny-
lated anti-PC-1 monoclonal antibody.23
Statistics
Values are expressed as mean7standard error (s.e.m.).
Comparisons of variables before and after weight loss were
performed with a paired t-test. Relationships between
variables and changes in the variables with weight loss were
determined with Pearson product correlations. Significance
was denoted at Po0.05.
Results
Subject characteristics
Clinical and anthropometric data on nine subjects prior
to and after surgery are shown (Table 1). Four of the
subjects were classified as diabetic prior to surgery,
having fasting glucose values4127 mg/dl: all achieved
normoglycemia after surgery. There was no difference
between the diabetic and nondiabetic morbidly obese
subjects on any clinical or biochemical measure of insulin
action. Further, there was no difference between these
groups in the effect of weight loss on any variable except
fasting glucose. Thus, data from all the nine subjects were
analyzed together.
Weight loss
All subjects had dramatic weight loss post surgery. They lost
an average of 48.375.6 kg over the 1 y period following
surgery; individual weight loss varied from 27.7 to 72.7 kg
(Table 1). BMI was reduced from 47.172.4 to 30.471.4 kg/
m2 (Figure 1).
Insulin sensitivity assessment
Insulin action in the subjects was assessed by FSIVGTT;
minimal model analysis was employed to calculate SI(20).
This value increased five-fold from 0.72 to 3.86 (min1/mU/
ml) (Table 1). In accordance with this increase in insulin
sensitivity, fasting plasma insulin levels fell five-fold from 30
to 6mU/ml (Table 1).
Insulin receptor content in muscle biopsies
Weight loss was associated with a doubling of the IR content
in skeletal muscle biopsies from 2.170.4 to 4.370.7 ng/mg
Skeletal muscle IR content after bariatric surgery
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protein (Figure 2). When IR content was plotted as a
function of fasting insulin concentration, it was observed
that IR content fell markedly over the insulin range of 2–20
(Figure 3a). Within this range, IR content correlated with the
log of fasting insulin (r¼0.75, Po0.005). Once IR content
reached a minimum value (B1.5 ng IR/mg protein), higher
insulin levels no longer corresponded to lower IR content.
The highest increases in IR were observed in those patients
with the greatest decrease in fasting insulin (Figure 3b). A
linear relationship was observed between these two para-
meters for decreases in fasting insulin greater than 70%
(r¼0.92, Po0.01).
Insulin receptor function
When the group was studied as a whole, maximal insulin
stimulation of IR autophosphorylation was not significantly
increased after weight loss (0.4770.05 vs 0.5370.04 OD
units/ng IR, pre- vs post-weight loss, respectively) (Figure 4).
However, in the four subjects with lowest IR autopho-
sphorylation values before surgery, this parameter increased
significantly after surgery (Po0.01). Two patients were
initially diabetic and two were not.
PC-1 is an IR inhibitor.24 However, there was no change in
muscle PC-1 content after weight loss (16.871.2 vs
18.473.9 ng/mg, pre- vs post-weight loss, respectively).
Plasma adiponectin levels
Adiponectin, a cytokine released from adipose cells and
associated with increased insulin action,17 was measured
in the plasma (Figure 5). The mean adiponectin level
for all subjects increased by approximately 40% from
Figure 2 Skeletal muscle IR content in obese patients before and after
gastric surgery. Vastus lateralis biopsies were obtained from patients in the
fasted state before and after gastric surgery. IR content was measured by IR
ELISA. Postsurgery values were significantly different from presurgery values,
Po0.01.
Figure 3 (a) Plot of skeletal muscle IR content vs fasting plasma insulin
levels. (r¼0.75, Po0.005). (b) Change in skeletal muscle IR content
induced by gastric surgery vs change in fasting plasma insulin levels
(r¼0.92, linear-logarithmic plot, Po0.01).
Figure 1 Change in body mass indices of obese patients before and after
gastric surgery. Postsurgery values were significantly different from presurgery
values, Po0.001.
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7.471.6 to 10.371.4 mg/ml following gastric surgery
(Po0.05).
Discussion
In the present study, we evaluated insulin receptor content
and function in morbidly obese subjects following bariatric
surgery. Fasting insulin levels decreased and insulin sensi-
tivity markedly improved after weight loss. A key finding was
that, in skeletal muscle, a major target tissue for insulin
action, insulin receptor content increased two- fold. The
increase in IR content was related to the decrease in fasting
plasma insulin (Figure 3). In addition, for all patients, both
before and after surgery, muscle IR content was related to
fasting plasma insulin. It is likely therefore that the IR
content is regulated by plasma insulin levels.
Downregulation of IR number by insulin has been
demonstrated in vitro with several cell types.6,7,25 The
downregulation can be attributed to both the accelerated
degradation of IR-bound insulin and reduction of IR mRNA
levels.6 Analysis of the correlation between IR number and
plasma insulin levels in this study revealed a biphasic
relationship. When our patients’ fasting plasma insulin
levels were less than 20 mU/ml, we observed a strong
correlation between IR number and fasting plasma insulin.
When the patient’s fasting plasma insulin level exceeded
20 mU/ml, downregulation of IR content appeared to reach
its maximum. In contrast, in vitro, the downregulation of IR
has been demonstrated across several orders of magnitude of
insulin concentration.26 This observation therefore raises the
possibility that the mechanisms of IR downregulation in vivo
are more complex than those in tissue culture.
In obese subjects, employing diazoxide to suppress insulin
secretion, Wigand and Blackard27 demonstrated that hyper-
insulinemia was at least partly responsible for downregulat-
ing cellular IR content; however, the direct effects of the
agent on this process could not be ruled out. IR content was
also decreased in studies of several hyperinsulinemic states,
including insulinoma patients28 and obesity.29 IR mRNA is
not reported to be diminished in obese, insulin-resistant
subjects.30
IR function is also modified by changing physiological
conditions. We have previously demonstrated, employing
the IR ELISA technique used herein, that IR autophosphor-
ylation is decreased with increasing obesity.11 Others have
reported that IR function is impaired in muscle biopsies from
obese subjects.8–10 In earlier studies, we have demonstrated
that insulin-stimulated IR autophosphorylation is improved
in muscle from subjects following a 7-day exercise training
program.31 Conversely, we have shown that high-fat feeding
in rats can induce impairments in IR autophosphorylation
within 2 weeks, which is before the acquisition of increased
fat stores occurs.32 In this study, we found increases in IR
autophosphorylation following bariatric surgery in the four
subjects with the lowest pre-surgery IR autophosphorylation.
However, the increase in this parameter for all patients did
not reach statistical significance. Since analyses were per-
formed using high insulin levels to stimulate the IR, it is
possible that, at lower physiological levels, a significant
difference may have been observed. It is also possible that
regulation of IR function in obese patients is heterogeneous
and that IR autophosphorylation, as analyzed herein, is
improved by bariatric surgery and subsequent weight loss in
some, but not all, patients.
The hormonal or metabolic pathways that couple in-
creased whole body fat stores with impaired insulin signaling
are unclear. It is known that elevated free fatty acids and
triglycerides have detrimental effects on insulin signaling
and that adipose tissue also plays a regulatory role.33–36
Figure 4 IR autophosphorylation in muscle samples before and after gastric
surgery. Skeletal muscle biopsies were obtained in the fasted state. Tissue was
solubilized, and insulin stimulation (100 nM) of IR autophosphorylation was
measured by specific ELISA, as described in Materials and methods. For each
sample, the data were normalized per 10 pg IR.
Figure 5 Fasting plasma adiponectin levels in obese patients before and
after gastric surgery. The differences between the two groups were significant,
Po0.05.
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Adiponectin is an adipocyte-secreted peptide that may effect
obesity-associated insulin resistance.17,37 Adiponectin levels
are reduced in obesity and increase following weight loss. We
have recently demonstrated that plasma adiponectin is
significantly correlated with IR signaling capacity.38 More-
over, administration of adiponectin improves insulin sensi-
tivity in animal models of lipoatrophic insulin resistance and
obesity,39 perhaps by either lowering hepatic glucose
production, or by increasing muscle fatty acid oxidation
via its effects to activate AMP kinase.39,40 In the present
study, adiponectin levels increased following weight loss. It
is possible, therefore, that increases in adiponectin may
contribute to improvements in insulin sensitivity resulting
from weight loss. In support of this hypothesis, it has
recently been demonstrated that the increase of adiponectin
in morbidly obese subjects after weight loss induced by
gastric bypass surgery was predictive of improved insulin
sensitivity, as assessed by the HOMA-IR calculation.41 The
present studies extend this observation with a more specific
measurement of insulin sensitivity, the SI.
In summary, we found that surgically induced weight loss
in morbidly obese subjects resulted in a dramatic improve-
ment in whole body insulin sensitivity, concomitant with a
fall in plasma insulin levels. In all subjects, these changes
were associated with an increase in the skeletal muscle IR
content, and in subjects with the lowest IR function, there
was an increase in IR function. In addition, we observed an
increase in plasma adiponectin levels. It is likely, therefore,
that changes in IR content and function, along with changes
in other parameters, such as increased adiponectin produc-
tion, and decreased tissue fat deposition, contribute to the
regulation of insulin sensitivity.
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